Clinical Trial Update: A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal Women [Phase 2]

View source ↗

Summary

Clinical trial update describing a Phase 2 study to identify the best dose of HS-10384 for treating vasomotor symptoms in postmenopausal women, with the trial s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasomotor Symptoms

Drugs mentioned

• HS-10384

Snippet

Sponsor: Hansoh BioMedical R&D Company | Conditions: Vasomotor Symptoms | Phase 2 | Status: NOT_YET_RECRUITING